Izervay logo

What you may pay

for IZERVAY


Price information below

The cost of IZERVAY™ (avacincaptad pegol intravitreal solution) may differ from person to person depending on insurance plans and other factors. We are committed to helping you understand your potential out‑of‑pocket (OOP) costs for IZERVAY.

You’ll find the following information on this site:

  • The list price of IZERVAY
  • Potential out‑of‑pocket cost with coverage
  • Financial support programs that may be available to you

List price

The price shown below is the list price that a patient without prescription insurance might pay for IZERVAY.

$2,100

per month*

How much you will pay depends on your prescription insurance coverage.

Only your insurance company or doctor can tell you the exact amount you will pay. Please contact them for specific cost information.

One month = ~28 ± 7 days.

*AnalySource® exported 8/6/24.

The information provided here by Astellas is an estimate of probable costs. Such information may be subject to change. Patients should always check with their insurance provider for complete and accurate information about their specific out-of-pocket costs for IZERVAY.


We can help you figure out what you might pay for IZERVAY

Just choose one of the following:

Medicare Part B or Medicaid

You have prescription insurance through a government-sponsored program

Medicare Part B
or Medicaid

Medicare Part B or Medicaid

Commercial Insurance

You have prescription insurance through your employer or purchased directly by you

Commercial Insurance

Commercial Insurance

Uninsured

You don't have prescription insurance, or your current prescription insurance doesn't cover IZERVAY

Uninsured

Uninsured

Medicare Part B

If you have Medicare Part B, your insurance may cover 80% of the cost for IZERVAY after deductible.

AVERAGE OUT-OF-POCKET (OOP) COST

The average OOP cost a patient with Medicare Part B insurance may pay for IZERVAY:

$505 a month**

If you have supplemental insurance, your cost may be lower or even covered in full.

Medicaid

If you have Medicaid insurance, your average OOP costs vary state by state.

One month = ~28 ± 7 days.

**Symphony Health, an ICON plc Company, PatientSource®, April 1, 2024 to June 30, 2024.

OOP cost = The final cost that patient pays (post-secondary insurance and/or
savings card, if applicable).

Actual patient OOP costs may vary based on insurance coverage, benefit design, and eligibility for support programs.

If you have a commercial insurance plan, your IZERVAY prescription could be covered.

AVERAGE OUT-OF-POCKET (OOP) COST

The average OOP cost a patient with commercial insurance may pay for IZERVAY:

$366 a month**

How much you pay depends on your coverage. To find out the exact cost of your prescription, contact your commercial insurance company or doctor.

Eligible patients may pay as little as $0 with the IZERVAY Commercial Copay Program. View the complete terms and conditions.

One month = ~28 ± 7 days.

**Symphony Health, an ICON plc Company, PatientSource®, April 1, 2024 to June 30, 2024.

OOP cost = The final cost that patient pays (post-secondary insurance and/or savings card, if applicable).

Actual patient OOP costs may vary based on insurance coverage, benefit design, and eligibility for support programs.

The IZERVAY Patient Assistance Program provides IZERVAY at no cost to uninsured/underinsured patients who meet the program eligibility requirements. View the complete terms and conditions.


If you need help with the cost of IZERVAY, we may be able to help:

Izervay my way

Our IZERVAY My WaySM patient support program is designed to meet the unique needs of eligible patients. Whether you have commercial insurance, insurance that doesn’t cover IZERVAY, are uninsured, or have government-issued insurance (such as Medicare), help may be available. 

Speak with your doctor to see if you are eligible for IZERVAY financial assistance programs or call 1-888-C5MYWAY (1-888-256-9929).

Learn more about IZERVAY
Astellas logo

Copyright © 2024 Astellas Pharma Inc. or its affiliates. All trademarks are the property of their respective owners.
US-AP-2400199 08/24